Key result
Intravenous nitrates showed no consistent beneficial effect on mortality in patients with acute heart failure syndromes across 15 trials, highlighting a lack of robust data.
Why the study?
Do intravenous nitrates improve clinical outcomes including mortality in patients with acute heart failure syndrome?
Systematic Review (n=1,824)
Do intravenous nitrates improve clinical outcomes including mortality in patients with acute heart failure syndrome?
There is a lack of robust evidence from randomized trials to support the widespread use of intravenous nitrates for acute heart failure syndromes, highlighting the need for modern studies.
No support for routine intravenous nitrates to reduce mortality in acute heart failure; leaves open need for modern randomized trials.
Intravenous nitrates are widely used in the management of acute heart failure syndrome (AHFS) yet with lack of robust evidence to support their use. We therefore sought to analyze all randomized studies that evaluated the effects of nitrates on clinical outcomes in patients with AHFS. In total, 15 relevant trials comparing nitrates and alternative interventions in 1824 patients were identified. All but 3 were conducted before 1998. No trials demonstrated a beneficial effect on mortality, apart from 1 trial reporting a reduction in mortality, which was related to the time of treatment. Retrospective review suggests that there is a lack of data to draw any firm conclusions concerning the use of nitrates in patients with AHFS. More studies are needed to evaluate the safety and efficacy of these agents in the modern era of guideline-directed use of heart failure therapy.
No takes yet. Share an insight, caveat, or question.
Farag et al. (2016) conducted a systematic review in Acute Heart Failure Syndromes (n=1,824). Intravenous nitrates vs. Alternative interventions was evaluated on Mortality. Intravenous nitrates showed no consistent beneficial effect on mortality in patients with acute heart failure syndromes across 15 trials, highlighting a lack of robust data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: